Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea · Delayed Price · Currency is KRW 10,710
-280 (-2.55%)
Jun 4, 2026, 2:35 PM KST
KRX:271980 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 160,141 | 220,758 | 166,115 | 249,173 | 306,002 | 494,458 | |
Market Cap Growth | -10.72% | 32.90% | -33.33% | -18.57% | -38.11% | -45.95% |
Enterprise Value | 234,748 | 296,796 | 219,930 | 307,855 | 346,161 | 503,450 |
Last Close Price | 10990.00 | 15150.00 | 11400.00 | 17100.00 | 20937.61 | 33666.10 |
PE Ratio | 7.86 | 9.44 | - | 49.79 | - | - |
PS Ratio | 0.30 | 0.39 | 0.24 | 0.34 | 0.42 | 0.71 |
PB Ratio | 0.62 | 0.88 | 0.76 | 1.46 | 1.87 | 2.96 |
P/TBV Ratio | 0.78 | 1.09 | 0.91 | 1.62 | 1.99 | 3.01 |
P/FCF Ratio | - | - | - | - | - | 35.94 |
P/OCF Ratio | - | - | 51.70 | - | - | 25.89 |
EV/Sales Ratio | 0.44 | 0.52 | 0.31 | 0.42 | 0.48 | 0.72 |
EV/EBITDA Ratio | 8.29 | 8.91 | - | 16.50 | - | - |
EV/EBIT Ratio | 14.80 | 14.14 | - | 34.64 | - | - |
EV/FCF Ratio | -20.63 | - | - | - | - | 36.60 |
Debt / Equity Ratio | 0.38 | 0.37 | 0.35 | 0.42 | 0.33 | 0.29 |
Debt / EBITDA Ratio | 3.44 | 2.80 | - | 3.82 | - | - |
Debt / FCF Ratio | - | - | - | - | - | 3.48 |
Net Debt / Equity Ratio | 0.12 | 0.14 | 0.08 | 0.21 | 0.14 | 0.12 |
Net Debt / EBITDA Ratio | 1.07 | 1.04 | -2.51 | 1.90 | -5.12 | -15.87 |
Net Debt / FCF Ratio | -2.67 | -2.52 | -17.13 | -3.21 | -0.87 | 1.44 |
Asset Turnover | 1.05 | 1.10 | 1.39 | 1.54 | 1.64 | 1.68 |
Inventory Turnover | 3.15 | 3.39 | 4.92 | 5.19 | 5.61 | 5.15 |
Quick Ratio | 0.88 | 0.82 | 0.79 | 0.66 | 0.71 | 0.78 |
Current Ratio | 1.35 | 1.29 | 1.18 | 1.04 | 1.12 | 1.28 |
Return on Equity (ROE) | 13.09% | 13.61% | -15.45% | 3.11% | -9.06% | -8.82% |
Return on Assets (ROA) | 1.94% | 2.53% | -2.29% | 1.18% | -1.89% | -1.55% |
Return on Invested Capital (ROIC) | 5.23% | 7.35% | -8.36% | 4.52% | -7.13% | -5.16% |
Return on Capital Employed (ROCE) | 5.80% | 7.80% | -7.90% | 4.90% | -6.80% | -5.10% |
Earnings Yield | 12.77% | 10.59% | -18.04% | 2.01% | -4.28% | -2.52% |
FCF Yield | -7.11% | -6.22% | -0.64% | -4.45% | -8.57% | 2.78% |
Dividend Yield | - | - | - | 0.29% | 0.24% | - |
Payout Ratio | - | - | - | 14.55% | - | - |
Buyback Yield / Dilution | -0.39% | -0.02% | 0.02% | 0.02% | 0.23% | 0.04% |
Total Shareholder Return | -0.39% | -0.02% | 0.02% | 0.31% | 0.47% | 0.04% |